Pablo Rodriguez‐Viciana

University College London — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index7.7kcitations67works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(22), Chronic Lymphocytic Leukemia Research(19), PI3K/AKT/mTOR signaling in cancer(17), Protein Tyrosine Phosphatases(16), Melanoma and MAPK Pathways(13)

Publications67 total

eLife Assessment: Acquired resistance to sotorasib in KRASG12C mutant NSCLC is vulnerable to PI3K-mTOR pathway inhibition mediated by 4E-BP1 regulator of cap-dependent translation
2025Open Access
RAS Family Interactions: The SHOC2-MRAS-PP1 Complex in Noonan Syndrome
2024
Supplementary Figure 1 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Tables 1-5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 1 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 2 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Tables 1-5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 3 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Data from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Data from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 4 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Methods from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 2 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Methods from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 3 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
Supplementary Figure 4 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Frank McCormick(22), David Stokoe(11), Nicole Hartig(11), Katsutoshi Oda(10), Luika Timmerman(10), Keiko Shoji(10), Yuji Taketani(10), Hiroyuki Kuramoto(10), Zachary A. Knight(10), Kevan M. Shokat(10), Julian Downward(9), Lucy C. Young(9), Jennifer Okada(9), Juan A. Osés-Prieto(6), Alma L. Burlingame(6), Marta Muñoz-Alegre(6), Patricia H. Warne(5), Katherine A. Rauen(4), Stephen Henderson(4), Isabel Boned del Río(4)